This study indicated that the C/G allele polymorphisms in the TRAIL gene at position 1525/1595 were higher in NAFLD than healthy individuals, associating with increased serum TRAIL18. The gene discussed is TNFSF10; the disease is metabolic dysfunction-associated steatotic liver disease.